Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
allergan
4
×
biotech
boston blog main
clinical trials
crispr
4
×
life sciences
national blog main
abbvie
boston top stories
editas medicine
san francisco blog main
alzheimer's disease
boston
boulder/denver blog main
boulder/denver top stories
cancer
cynthia collins
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
gene editing
indiana blog main
indiana top stories
ipo
national
national top stories
new york blog main
new york top stories
parkinson's disease
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
sanofi
seattle blog main
seattle top stories
What
bio
ceo
editas
editing
experimental
gene
medicines
roundup
abbvie
acquisitions
allergan
alliance
announced
biotech
black
blessing
bosley
check
clinical
collabs
companies
continue
covid
crispr
cusp
daniel
deal
debut
depart
diamond
diamond’s
exits
genetic
gilead
gilead’s
help
humans
indication
introduce
ipo
Language
unset
Current search:
photo
×
crispr
×
allergan
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial